For instance, the expression of ATP1A1 is significantly lower in prostate carcinoma than in normal and prostatic hyperplasia glands [9, 14], and its down-regulation of ATP1A1 leads to a decrease of the Na+, K+-ATPase activity in carcinoma [7]. This evidence concerns the gene ATP1A1 and prostate carcinoma.